Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Published starting price: $99 per month
Springer International Publishing, pp 123
Image Credit: Love Employee / Shutterstock In a recent study published in the journal Nature Medicine , researchers compared major adverse cardiovascular events (MACE) between glucagon-like peptide-1 (GLP-1) receptor agonists and comparators, benchmarking real-world estimates against randomized trial data to guide clinical decision-making
PMID: 27186127 | doi:10.2147/JEP.S35396 Beck DE et al
Say no more
Originally developed for diabetes control, semaglutide has become a popular choice for people looking to lose weight due to its effects on appetite and metabolism
